Cerebellum’s Conduent CNDT Stock Holding History

Cerebellum’s Portfolio CNDT Stock Details CNDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-63,526	Closed	-$395K	–	442
2019 Q3	$395K	Buy	+63,526	New	+$491K	0.25%	303
2019 Q2	–	Sell	-24,543	Closed	-$339K	–	446
2019 Q1	$339K	Sell	24,543 -1,069	-4%	-$14.2K	0.29%	70
2018 Q4	$272K	Buy	25,612 +17,284	+208%	+$269K	0.19%	9
2018 Q3	$188K	Buy	+8,328	New	+$171K	0.3%	77

Other funds holding CNDT

Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cerebellum's CNDT Position: Q4 2019 in Review

Cerebellum sold out of Conduent (CNDT) in Q4 2019, closing a stake of 63,526 shares — an estimated $395K sold.

Cerebellum first reported a position in CNDT in Q3 2018 and held it in 4 quarters. The position peaked at $395K in Q3 2019. 241 funds tracked by Wall St. Rank hold CNDT as of Q4 2019.

Cerebellum reported no remaining Conduent position as of Q4 2019 after selling out during the quarter.
Cerebellum sold 63,526 Conduent shares in Q4 2019, an estimated $395K.
Cerebellum first reported a position in Conduent in Q3 2018 and held it in 4 quarters.
Cerebellum's Conduent position peaked at $395K in Q3 2019.
241 funds tracked by Wall St. Rank held Conduent as of Q4 2019.

Based on Cerebellum's 13F filing for Q4 2019, filed 16 Jan 2020.